Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	86.91B
Revenue (ttm)	2.49B
Net Income (ttm)	-294.04M
Shares Out	1.27B
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	46.47
Dividend	0.32 (0.48%)
Ex-Dividend Date	Jun 3, 2024

Volume	6,076,405
Average Volume	3,510,241
Open	66.79
Previous Close	66.80
Day's Range	66.51 - 70.49
52-Week Range	61.90 - 89.89
Beta	2.25
RSI	53.56
Earnings Date	Apr 12, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. The company was founded in 1991 and is headquartered in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 3,843
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

In 2023, SHA:603392's revenue was 5.51 billion, a decrease of -50.73% compared to the previous year's 11.19 billion. Earnings were 1.25 billion, a decrease of -73.65%.